(Reuters) -Only about 2.8 million Americans had received a COVID-19 vaccine going into the last day of December, putting the United States far short of the government’s target to vaccinate 20 million people this month.
Shots are reaching nursing home residents at an even slower pace than others first in line even though they are most at risk of dying of the virus.
Only 170,000 people in long-term care facilities received a shot as of Dec. 30 even though 2.2 million doses were distributed for residents, according to data released from the Centers for Disease Control and Prevention.
About 14 million doses of Pfizer’s and Moderna’s vaccines have been distributed to states so far, federal officials told reporters on Wednesday, shy of its goal to ship 20 million doses this month.
Both Pfizer and Moderna, the two major drug manufacturers likely to receive emergency authorizations for a Covid-19 vaccine in the coming weeks, have rejected invitations from President Trump to appear at a White House “Vaccine Summit” on Tuesday, according to two sources familiar with the event’s planning.
The Trump administration has openly feuded with Pfizer in recent weeks over its involvement in Operation Warp Speed and the timing of a data release showing its vaccine to be highly effective, but had nonetheless invited CEO Albert Bourla to appear on a panel about the vaccine development process. Moderna CEO Stéphane Bancel was also invited, but neither he nor another company executive will attend.
The vaccine manufacturers’ absences will be conspicuous at a “Vaccine Summit,” an event that drug industry figures and one Trump administration official largely viewed as a public relations stunt when STAT first reported the event last week.
The drug company Moderna announced that it would be submitting its coronavirus vaccine for emergency approval from the FDA on Monday, following clinical trial data showing its shots are very effective at preventing cases of COVID-19.Once submitted, Moderna’s will be the second coronavirus vaccine on its way to emergency approval from the US health agency. Pfizer submitted its vaccine for approval earlier this month.
Today’s Top Stories is brought to you by My Daily Grind News.
Trump probably lied about taking malaria drug, hydroxychloroquine.
(CNN) The fragile foundation of evidence-based reality shoring up Donald Trump’s life and presidency just got even more tenuous.Trump’s admission that he was dosing up on hydroxychloroquine, an unproven and possibly harmful therapy to ward off the coronavirus, appears to conflict with the codes of medical science and is a stunning development given his position.
“Here’s my evidence: I get a lot of positive calls about it,” Trump told shocked reporters when he made the disclosure about a malaria drug he has all but dispensed from the bully pulpit. Trump’s medical choices and the risks he chooses to take are his personal business. But he is not an ordinary citizen, and his use of the therapy sends a conflicting message to Americans told by the US Food and Drug Administration that it is not proven to work against Covid-19 and could be counterproductive.
The President’s preventative pitch even prompted the anchor on duty at the friendly confines of Fox News to warn that some viewers could die if they followed his example. It was not the only moment on Monday when Trump’s personal and political priorities brought him into a collision with evidence. He grouched that Attorney General William Barr said he’s not inclined to pursue criminal charges in a false conspiracy theory against former President Barack Obama and Trump’s 2020 foe, Joe Biden.
“I think if it was me they would do it,” Trump said.
Trump will not invite Obama to White House for traditional unveiling of the most recent ex-president’s portrait – White House portrait unveiling may be the latest casualty of the political divide
Treasury Secretary Steve Mnuchin and Fed Chairman Jerome Powell testify before Congress this morning.
Learn how to turn your hobbies into hustles – check out Gig Economics.